stockrowHenry Schein, Inc.
HSIC Healthcare Medical Distribution
Henry Schein, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.2 billion, up 4.03% from fiscal 2024.
- Revenue
- +3.95%
- EPS
- +34.8%
- Free cash flow
- −7.09%
- Total debt
- +15.6%
Quarter to September 2026, against a year earlier
Follow HSIC
Alert me
Henry Schein, Inc. (HSIC) Return on assets
Henry Schein, Inc.'s return on assets over the twelve months to 30 September 2026 was 3.72%, up 0.0 percentage points from fiscal 2025 (3.71%). Over the past ten years it has ranged from 3.71% (fiscal 2025) to 8.88% (fiscal 2019) — the current reading is the lowest in ten years. That is above the Medical Distribution industry median of −1.95% and above the Healthcare sector median of −29.3%.
Return on assets, annual
Embed this chart
Annual newest first
| Period | Return on assets | Change (points) |
|---|---|---|
| FY2025 | 3.71% | (0.04) |
| FY2024 | 3.75% | (0.59) |
| FY2023 | 4.34% | (1.96) |
| FY2022 | 6.30% | (1.46) |
| FY2021 | 7.76% | 2.35 |
| FY2020 | 5.41% | (3.47) |
| FY2019 | 8.88% | 2.33 |
| FY2018 | 6.55% | 0.99 |
| FY2017 | 5.56% | (2.08) |
| FY2016 | 7.64% | 0.06 |
Against its own ten years
Return on assets against peers
| Company | Return on assets |
|---|---|
| MCK McKesson Corporation compare | 5.33% |
| COR Cencora, Inc. compare | 4.26% |
| HSIC Henry Schein, Inc. | 3.72% |
| CAH Cardinal Health, Inc. compare | 3.17% |
| AHG Akso Health Group Sponsored ADR compare | 0.00% |
| YI 111, Inc. Sponsored ADR compare | −3.89% |
| ACH Accendra Health, Inc. compare | −9.65% |
| COSM Cosmos Health Inc. compare | −39.6% |
| FOCL FocalTherics compare | −50.3% |
| Medical Distribution industry median | −1.95% |
| Healthcare sector median | −29.3% |
| Market median | 0.00% |
What Return on assets is
ROA tells an investor how much profit a company earns for shareholders from the assets it uses to run its business.
Annual: Net Income Allotted to Shareholders ÷ Average Assets; TTM: Net Income Allotted to Shareholders ÷ Average Assets (latest quarter)
More on HSIC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement